yttrium Y 90 anti-CD45 monoclonal antibody BC8
Term · Oncology and biomedicine · MLC-T-ONC-017623
A radioimmunoconjugate containing the murine IgG1 anti-CD45 monoclonal antibody (MoAb) BC8 labeled with yttrium 90 (Y90), with potential immunotherapeutic activity. Yttrium Y 90 anti-CD45 monoclonal antibody BC8 binds to CD45 antigen, a receptor protein-tyrosine phosphatase expressed on the surface of both normal and malignant hematopoietic cells. After binding and internalization by CD45-expressing tumor cells, this agent may deliver a cytotoxic dose of beta radiation.
| Identifier | MLC-T-ONC-017623 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 90Y anti-CD45 MAb BC8 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017623",
"term": "yttrium Y 90 anti-CD45 monoclonal antibody BC8",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate containing the murine IgG1 anti-CD45 monoclonal antibody (MoAb) BC8 labeled with yttrium 90 (Y90), with potential immunotherapeutic activity. Yttrium Y 90 anti-CD45 monoclonal antibody BC8 binds to CD45 antigen, a receptor protein-tyrosine phosphatase expressed on the surface of both normal and malignant hematopoietic cells. After binding and internalization by CD45-expressing tumor cells, this agent may deliver a cytotoxic dose of beta radiation.",
"abbreviation": "90Y anti-CD45 MAb BC8",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/yttrium-y-90-anti-cd45-monoclonal-antibody-bc8/"
}
Record 17,558 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.